Investigating the possible effects of AKT and FAK signaling pathways' inactivation on TNBC cell proliferation and TNBC patients' recurrence free survival via BAG3 regulation

Ben Xue

doi:10.54254/2753-8818/45/20240784

Article Information

Received: 5 July 2024

Published: 26 July 2024

DOI: https://doi.org/10.54254/2753-8818/45/20240784

Article Type: Research Article

Cite this article

Xue,B. (2024). Investigating the possible effects of AKT and FAK signaling pathways' inactivation on TNBC cell proliferation and TNBC patients' recurrence free survival via BAG3 regulation. Theoretical and Natural Science,45,283-291.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About this Volume

Volume Title: TNS Vol.45

Part of Series: Theoretical and Natural Science

ISSN: 2753-8818 (Print) / 2753-8826 (Online)

Copyright & License

[1]American Cancer Society. (2022). American Cancer Society. https://www.cancer.org/cancer/ breast-cancer/about/types-of-breast-cancer/triple-negative.html#:%7E:text=Triple%2Dnegative%20breast%20cancer%20(TNBC,of%20the%20protein%20called%20HER2

[2]Shields, S., Conroy, E., O’Grady, T., McGoldrick, A., K.C., P.Ward, P., Useckaite, Z., Dempsey, E., Reilly, R., Fan, Y., Chubb, A., Gomez Matallanas, D., W. Kay, E., O’Connor, D., McCann, A., M. Gallagher, W., & Coppinger, J. A. (2018, May 20). BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884656/

[3]Ueno, N. T., & Zhang, D. (2011). Targeting EGFR in Triple Negative Breast Cancer. https://doi.org/10.7150/jca.2.324

[4]Thermo Fisher Scientific - HK. (2022). bt549 Cells. https://www.thermofisher.com/hk/en/home/ technical-resources/cell-lines/b/cell-lines-detail-446.html

[5]Yang, D., Peng, M., Hou, Y., Qin, Y., Wan, X., Zhu, P., Liu, S., Yang, L., Zeng, H., Jin, T., Qiu, Y., Li, Q., & Liu, M. (2020). Oxidized ATM promotes breast cancer stem cell enrichment through energy metabolism reprogram-mediated acetyl-CoA accumulation. https://doi.org/10.1038/s41419-020-2714-7

[6]Shields, S., Conroy, E., O’Grady, T., McGoldrick, A., Connor, K., Ward, M. P., Useckaite, Z., Dempsey, E., Reilly, R., Fan, Y., Chubb, A., Matallanas, D. G., Kay, E. W., O’Connor, D., McCann, A., Gallagher, W. M., & Coppinger, J. A. (2018). BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer. https://doi.org/10.18632/oncotarget.24590

[7]Avinery, L., Valid Gahramanov, Arkadi Hesin, & Sherman, M. Y. (2022). Hsp70–Bag3 Module Regulates Macrophage Motility and Tumor Infiltration via Transcription Factor LITAF and CSF1.Cancers, 14(17), 4168–4168. https://doi.org/10.3390/cancers14174168

[8]Zheng, D., Golubovskaya, V. M., Kurenova, E., Wood, C., Massoll, N. A., Ostrov, D. A., Cance, W. G., & Hochwald, S. N. (2009). A novel strategy to inhibit FAK and IGF-1R decreases growth of pancreatic cancer xenografts. Molecular Carcinogenesis, 49(2), 200–209. https://doi.org/10.1002/mc.20590

[9]Kumar, C., & Madison, V. (2005). AKT crystal structure and AKT-specific inhibitors. Oncogene, 24(50), 7493–7501. https://doi.org/10.1038/sj.onc.1209087

[10]Yang, L., Han, D., Sun, M., Liu, Q., Sun, X., Feldman, R. I., Hamilton, A. D., Polokoff, M. A., Nicosia, S. V., Meenhard Herlyn, SebtiS. M., & Cheng, J. Q. (2004). Akt/Protein Kinase B Signaling Inhibitor-2, a Selective Small Molecule Inhibitor of Akt Signaling with Antitumor Activity in Cancer Cells Overexpressing Akt. Cancer Research, 64(13), 4394–4399. https://doi.org/10.1158/0008-5472.can-04-0343